Squamous Non-Small Cell Lung Cancer:グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Squamous Non-Small Cell Lung Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Squamous Non-Small Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Squamous Non-Small Cell Lung Cancer 33
Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer 33
Aug 13, 2013: Eli Lilly and Company’s Phase III study of necitumumab meets primary endpoint 33
Jun 04, 2013: Debiopharm Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies For Patients With Selected Solid Malignancies 33
May 23, 2013: OncoGenex Pharma Announces Plans For Initiation Of Cedar Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer 34
Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Novartis AG 42
Clinical Trial Overview of Novartis AG 42
GlaxoSmithKline plc 43
Clinical Trial Overview of GlaxoSmithKline plc 43
Debiopharm International S.A. 44
Clinical Trial Overview of Debiopharm International S.A. 44
Agennix AG 45
Clinical Trial Overview of Agennix AG 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Clinical Trial Overview of Cancer Institute Hospital Japanese Foundation for Cancer Research 48
Rigshospitalet 49
Clinical Trial Overview of Rigshospitalet 49
Sarah Cannon Research Institute 50
Clinical Trial Overview of Sarah Cannon Research Institute 50
Wake Forest University 51
Clinical Trial Overview of Wake Forest University 51
Hiroshima University Hospital 52
Clinical Trial Overview of Hiroshima University Hospital 52
Eastern Cooperative Oncology Group 53
Clinical Trial Overview of Eastern Cooperative Oncology Group 53
Samsung Medical Center 54
Clinical Trial Overview of Samsung Medical Center 54
Five Key Clinical Profiles 55
Appendix 158
Abbreviations 158
Definitions 158
Research Methodology 159
Secondary Research 159
About GlobalData 160
Contact Us 160
Disclaimer 160
Source 161


【レポート販売概要】

■ タイトル:Squamous Non-Small Cell Lung Cancer:グローバル臨床試験動向(2014年上半期)
■ 英文:Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月26日
■ 調査会社:GlobalData
■ 商品コード:GDHC2164CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。